VACCINES FOR ACTINOBACILLUS PLEUROPNEUMONIAE
    5.
    发明申请
    VACCINES FOR ACTINOBACILLUS PLEUROPNEUMONIAE 审中-公开
    ACTINOBACILLUS PLEUROPNEUMONIAE的疫苗

    公开(公告)号:WO1993008283A1

    公开(公告)日:1993-04-29

    申请号:PCT/CA1992000460

    申请日:1992-10-21

    CPC classification number: C07K14/285 A61K39/00

    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one A. pleuropneumoniae transferrin binding protein and/or one A. pleuropneumoniae cytolysin and/or one A. pleuropneumoniae APP4. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.

    Abstract translation: 公开了用于针对放线杆菌胸膜肺炎放线芽孢杆菌的新型疫苗。 疫苗含有至少一种胸膜肺炎放线芽孢杆菌转运蛋白结合蛋白和/或一种胸膜肺炎放线芽孢杆菌细胞溶解素和/或一种胸膜肺炎放线菌APP4。 还公开了编码这些蛋白质的DNA序列,包括这些序列的载体和用这些载体转化的宿主细胞。 疫苗可用于治疗或预防猪呼吸道感染。

    CHIMERIC CAMP FACTORS FOR VACCINATION AGAINST STREPTOCOCCUS INFECTION
    6.
    发明申请
    CHIMERIC CAMP FACTORS FOR VACCINATION AGAINST STREPTOCOCCUS INFECTION 审中-公开
    针对结肠炎感染疫苗接种的重要因素

    公开(公告)号:WO2003091437A1

    公开(公告)日:2003-11-06

    申请号:PCT/CA2003/000587

    申请日:2003-04-24

    CPC classification number: C07K14/315 A61K39/00 C07K2319/02

    Abstract: The CAMP factor gene of Streptococcus uberis ( S. uberis ) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs, including CAMP factor epitopes from more than one bacterial species. The CAMP factors and chimeras including the same can be used in immunogenic compositions for the prevention and treatment of bacterial infections.

    Abstract translation: 描述了乳房链球菌(乳房链球菌)的CAMP因子基因,以及从其重组产生CAMP因子。 还公开了嵌合CAMP因子构建体,包括来自多于一种细菌种的CAMP因子表位。 包括其的CAMP因子和嵌合体可用于免疫原性组合物中用于预防和治疗细菌感染。

    COMPOSITIONS AND TREATMENTS FOR PNEUMONIA IN ANIMALS
    9.
    发明申请
    COMPOSITIONS AND TREATMENTS FOR PNEUMONIA IN ANIMALS 审中-公开
    动物中肺炎的组成和治疗

    公开(公告)号:WO1991015237A1

    公开(公告)日:1991-10-17

    申请号:PCT/CA1990000170

    申请日:1990-05-25

    CPC classification number: A61K39/102 A61K39/00 C07K14/285

    Abstract: New proteins and subunit antigens from P. haemolytica for use in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The subunit antigens include immunogenic amino acid sequences of P. haemolytica fimbrial protein, P. haemolytica plasmin receptor protein, and P. haemolytica 50 K outer membrane protein and P. haemolytica leukotoxin. The antigens can be used in a vaccine composition, either alone or in combination. Also disclosed are methods of vaccination as well as methods of making the subunit antigens employed in the vaccines.

    Abstract translation: 公开了用于刺激抗呼吸系统疾病例如肺炎的免疫的解脲索氏溶血杆菌的新蛋白质和亚基抗原,包括运​​送发热性肺炎。 亚单位抗原包括解脲葡萄球菌菌毛蛋白,溶血性解纤维细胞溶血素受体蛋白和溶血性解水多糖50K外膜蛋白和解放军溶血白细胞毒素的免疫原性氨基酸序列。 抗原可以单独或组合地用于疫苗组合物中。 还公开了接种疫苗的方法以及制备疫苗中使用的亚基抗原的方法。

    STREPTOCOCCUS UBERIS LACTOFERRIN-BINDING PROTEIN
    10.
    发明申请
    STREPTOCOCCUS UBERIS LACTOFERRIN-BINDING PROTEIN 审中-公开
    STREPTOCOCCUS UBERIS LACTOFERRIN-BINDING蛋白

    公开(公告)号:WO1998021231A2

    公开(公告)日:1998-05-22

    申请号:PCT/CA1997000867

    申请日:1997-11-14

    CPC classification number: C07K14/315 A61K39/00

    Abstract: The bovine lactoferrin (bLF) binding protein of Streptococcus uberis (S. uberis) is described, as well as the gene encoding the bLF (1bp). LF-binding proteins can be used in vaccine compositions for the prevention and treatment of S. uberis infections, particularly mastitis, as well as in diagnostic methods for determining the presence of S. uberis infections. Also disclosed is a regulatory region adjacent to 1bp, termed mga.

    Abstract translation: 描述了乳房链球菌(S.auberis)的牛乳铁蛋白(bLF)结合蛋白,以及编码bLF(1bp)的基因。 LF结合蛋白可用于预防和治疗乳房链球菌感染,特别是乳腺炎的疫苗组合物,以及用于确定乳房链球菌感染存在的诊断方法。 还公开了与1bp相邻的调节区,称为mga。

Patent Agency Ranking